Global burden of cancer in women, 1990–2021: a systematic analysis from the GBD 2021 study
Frontiers in Oncology · 11.08.2025 · 15
DOI: 10.3389/fonc.2025.1633894 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 11.08.2025. Verfasst von Yun Mao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The Second Affiliated Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, China. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Objective
This study evaluates global burden, disparities, and trends of female cancers (breast, cervical, uterine, ovarian) from 1990 to 2021, and identifies key contributing factors and intervention strategies.
Methods
Data from the Global Burden of Disease (GBD,1990–2021) Study and recent reports were analyzed to assess incidence, mortality, and disability-adjusted life years (DALYs) across 204 countries stratified by Socio-demographic Index (SDI). Regression and spatiotemporal analyses explored links with risk factors (e.g., obesity, HPV) and healthcare access.
Results
Breast cancer dominated the burden, with age-standardized incidence rates (ASIR) rising by 28% (2.08 million new cases in 2021), driven by lifestyle factors (high BMI, alcohol use) and showing a strong connection with higher SDI (r=0.82). Cervical cancer remained a critical challenge in low- and middle-income regions, showing a strong negative correlation with SDI(r = -0.75), though Age-Standardized Mortality Rate (ASMR) declined globally (-1.4% annual change). Uterine cancer incidence rose steadily (0.7% annual increase; 473,614 cases in 2021), primarily attributable to obesity, while ovarian cancer mortality remained high (207,000 deaths) due to late diagnosis. Key modifiable risks included HPV infection (85% of cervical cancers), tobacco use, and reproductive behaviors.
Conclusion
The global burden of female cancers presents a significant public health challenge. Disparities in female cancer burden reflect inequities in healthcare access and rising metabolic risks. Priority actions include HPV vaccination, low-cost screening, and obesity control. Equity-focused, data-informed policies are crucial to reduce global disparities.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oncology, The Second Affiliated Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, China.
- Department of Oncology, Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
- Nanfang Hospital, Southern Medical University, Guangzhou, China.
- College of Information and Electrical Engineering, China Agricultural University, Beijing, China.
- Department of Orthopedics and Traumatology, Huarong County Traditional Chinese Medicine Hospital, Yueyang, Hunan, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Mao, Y., Gao, Y., He, Y., Wan, Z., Li, S., Ding, Z., Hu, B., Fu, L., Luo, C., Zhu, S., & Cao, W. (2025). Global burden of cancer in women, 1990–2021: a systematic analysis from the GBD 2021 study. Frontiers in Oncology, 15. https://doi.org/10.3389/fonc.2025.1633894
Vancouver
Mao Y, Gao Y, He Y, Wan Z, Li S, Ding Z, et al. Global burden of cancer in women, 1990–2021: a systematic analysis from the GBD 2021 study. Frontiers in Oncology. 2025;15. doi:10.3389/fonc.2025.1633894
BibTeX
@article{Mao2025,
author = {Mao, Yun and Gao, Yebo and He, Yongjie and Wan, Zuihui and Li, Shuyu and Ding, Zhixun and Hu, Beier and Fu, Ling and Luo, Chao and Zhu, Shijie and Cao, Wen},
title = {Global burden of cancer in women, 1990–2021: a systematic analysis from the GBD 2021 study},
journal = {Frontiers in Oncology},
year = {2025},
volume = {15},
doi = {10.3389/fonc.2025.1633894}
}
EUVIMED